Current filters:

Start a new search
Add filters:

Use filters to refine the search results.

Results 1-10 of 17 (Search time: 0.01 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2001The relationship between mood state and plasma methadone concentration in maintenance patientsDyer, K.; White, J.; Foster, D.; Bochner, F.; Menelaou, A.; Somogyi, A.
2004Population pharmacokinetics of (R)-, (S)- and rac-methadone in methadone maintenance patientsFoster, D.; Somogyi, A.; White, J.; Bochner, F.
2004Comparison of tincture of opium and methadone to control opioid withdrawal in a Thai treatment centreJittiwutikarn, J.; Ali, R.; White, J.; Bochner, F.; Somogyi, A.; Foster, D.
2006Differential in vitro inhibition of M3G and M6G formation from morphine by (R)- and (S)-methadone and structurally related opioidsMorrish, G.; Foster, D.; Somogyi, A.
2004CYP2D6 and CYP3A4 involvement in the primary oxidative metabolism of hydrocodone by human liver microsomesHutchinson, M.; Menelaou, A.; Foster, D.; Coller, J.; Somogyi, A.
2012ABCB1 haplotype and OPRM1 118A > G genotype interaction in methadone maintenance treatment pharmacogeneticsBarratt, D.; Coller, J.; Hallinan, R.; Byrne, A.; White, J.; Foster, D.; Somogyi, A.
2000Steady-state pharmacokinetics of (R)- and (S)-methadone in methadone maintenance patientsFoster, D.; Somogyi, A.; Dyer, K.; White, J.; Bochner, F.
2000Stereoselective quantification of methadone and its major oxidative metabolite, 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine, in human urine using high-performance liquid chromatographyFoster, D.; Somogyi, A.; Bochner, F.
2007Lack of influence of CYP2D6 genotype on the clearance of (R)- (S)- and racemic-methadonColler, J.; Joergensen, C.; Foster, D.; James, H.; Gillis, D.; Christrup, L.; Somogyi, A.
2007Comparison of cerebral pharmacokinetics of buprenorphine and norbuprenorphine in an in vivo sheep modelJensen, M.; Foster, D.; Upton, R.; Grant, C.; Martinez, A.; Somogyi, A.